Close Menu

In PLoS One this week, investigators at Harvard Medical School and elsewhere report on a microdroplet-based method they've developed to rapidly isolate viable single cells from heterogeneous solutions in order to obtain total RNA from them. The team says its method, performed on an automated platform, enables "high-throughput cell manipulation for subsequent genomic analysis" and requires "fewer handling steps compared to existing methods."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.